Response to Wynn and Hokovec Regarding “The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”
We would like to thank Ms. Wynn and Ms. Hoskovec from BillionToOne for their interest in our paper based on the ISPD debate, “The use of cfDNA to screen for monogenic conditions in low risk populations is ready for clinical use"
Authors
- Sylvie Langlois (ORCID: https://orcid.org/0000-0001-9301-3625)
- Neeta L. Vora (ORCID: https://orcid.org/0000-0002-2504-9455)
- Lyn S. Chitty (ORCID: https://orcid.org/0000-0002-4857-7138)
Institutions
- University of North Carolina at Chapel Hill (US)
Publication Details
- Journal
- UNC Libraries
- Published
- 2025-09-15
- DOI
- https://doi.org/10.17615/59n1-rc53
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00